The CAP/CLIA Clinical Proteomics Laboratory, provides a unique opportunity to assess and evaluate new proteomic technologies under rigorous clinical guidelines; accelerate the verification and validation of promising candidate biomarkers in a clinical diagnostic setting; and implement unique clinical trials and diagnostic tests. The CAP Clinical Proteomics Laboratory uses an Aushon 2470 Automated, High-Throughput Protein Arrayer, and a Dako robotic autostainer to generate protein arrays and perform immunohistochemistry for analysis of tissue and cellular samples for biomarker discovery. An Immulite 1000 Immunoassay instrument is also available to measure protein analytes and perform clinical tests.